Related Experiment Videos
Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats
Sabina Semiz1, Chris Orvig, John H McNeill
1Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada.
Abstract:
In vivo effects of insulin and vanadium treatment on glycogen synthase (GS), glycogen synthase kinase-3 (GSK-3) and protein phosphatase-1 (PP1) activity were determined in Wistar rats with streptozotocin (STZ)-induced diabetes. The skeletal muscle was freeze-clamped before or following an insulin injection (5 U/kg i.v.). Diabetes, vanadium, and insulin in vivo treatment did not affect muscle GSK-3beta activity as compared to controls. Following insulin stimulation in 4-week STZ-diabetic rats muscle GS fractional activity (GSFA) was increased 3 fold (p < 0.05), while in 7-week diabetic rats it remained unchanged, suggesting development of insulin resistance in longer term diabetes. Muscle PP1 activity was increased in diabetic rats and returned to normal after vanadium treatment, while muscle GSFA remained unchanged. Therefore, it is possible that PP1 is involved in the regulation of some other cellular events of vanadium (other than regulation of glycogen synthesis). The lack of effect of vanadium treatment in stimulating glycogen synthesis in skeletal muscle suggests the involvement of other metabolic pathways in the observed glucoregulatory effect of vanadium.
Insights
Vanadium treatment normalized protein phosphatase-1 (PP1) activity in diabetic rats, but did not improve glycogen synthesis, suggesting other metabolic pathways are involved in vanadium's glucose-lowering effects.
Area of Science:
- Biochemistry
- Endocrinology
- Metabolic Research
Background:
- Streptozotocin (STZ)-induced diabetes in rats is a model for studying metabolic dysfunction.
- Insulin and vanadium are investigated for their roles in glucose metabolism and insulin signaling pathways.
Purpose of the Study:
- To investigate the in vivo effects of insulin and vanadium on key enzymes involved in glycogen metabolism in diabetic rats.
- To assess the impact of diabetes duration on insulin sensitivity and the response to vanadium treatment.
Main Methods:
- Wistar rats were induced with STZ to create a diabetic model.
- Skeletal muscle tissue was collected and analyzed for the activity of glycogen synthase (GS), glycogen synthase kinase-3 (GSK-3), and protein phosphatase-1 (PP1).
- Enzyme activities were measured before and after insulin stimulation, and following vanadium treatment.
Main Results:
- Insulin treatment significantly increased muscle glycogen synthase fractional activity (GSFA) in short-term (4-week) diabetic rats, but not in long-term (7-week) diabetic rats, indicating developed insulin resistance.
- Vanadium treatment normalized increased muscle protein phosphatase-1 (PP1) activity in diabetic rats.
- Vanadium treatment did not alter muscle GSFA in diabetic rats, suggesting its glucoregulatory effects may involve pathways beyond direct glycogen synthesis stimulation.
Conclusions:
- Insulin resistance develops with longer duration of STZ-induced diabetes.
- Vanadium's effect on normalizing PP1 activity suggests its involvement in other cellular processes distinct from direct glycogen synthesis regulation.
- The glucoregulatory effects of vanadium in this model likely involve metabolic pathways other than those directly stimulating skeletal muscle glycogen synthesis.